Encompass Health Co. (NYSE:EHC – Get Free Report) gapped down before the market opened on Tuesday after Barclays lowered their price target on the stock from $113.00 to $109.00. The stock had previously closed at $89.67, but opened at $86.14. Barclays currently has an overweight rating on the stock. Encompass Health shares last traded at $85.33, with a volume of 106,150 shares trading hands.
A number of other research analysts have also issued reports on EHC. Raymond James reaffirmed a “strong-buy” rating and set a $95.00 target price (up from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Truist Financial lifted their target price on Encompass Health from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, July 15th. Royal Bank of Canada lifted their target price on Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a report on Wednesday, July 10th. Finally, Stephens reaffirmed an “overweight” rating and set a $94.00 target price on shares of Encompass Health in a report on Wednesday, June 5th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $99.86.
Insider Buying and Selling
In related news, insider Elissa Joy Charbonneau sold 10,000 shares of Encompass Health stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $85.02, for a total value of $850,200.00. Following the transaction, the insider now owns 18,594 shares of the company’s stock, valued at approximately $1,580,861.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Encompass Health
Several institutional investors and hedge funds have recently bought and sold shares of EHC. Principal Securities Inc. purchased a new position in Encompass Health during the 4th quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. grew its stake in Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after acquiring an additional 317 shares in the last quarter. GAMMA Investing LLC purchased a new position in Encompass Health during the 4th quarter valued at about $33,000. Parallel Advisors LLC grew its stake in Encompass Health by 192.3% during the 4th quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock valued at $38,000 after acquiring an additional 377 shares in the last quarter. Finally, Oakworth Capital Inc. purchased a new position in Encompass Health during the 2nd quarter valued at about $40,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.
Encompass Health Trading Down 5.5 %
The firm has a market capitalization of $8.53 billion, a price-to-earnings ratio of 22.90, a price-to-earnings-growth ratio of 1.45 and a beta of 0.89. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. The company has a fifty day moving average price of $86.45 and a 200-day moving average price of $81.34.
Encompass Health (NYSE:EHC – Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.10. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.95 EPS. On average, equities research analysts predict that Encompass Health Co. will post 4.09 EPS for the current year.
Encompass Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be issued a $0.17 dividend. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 0.80%. The ex-dividend date is Tuesday, October 1st. Encompass Health’s payout ratio is 18.38%.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
